Title : Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma.

Pub. Date : 2012 Dec

PMID : 23308050






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma. Valproic Acid killer cell lectin like receptor K1 Homo sapiens
2 In this study, we tested the effect of valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, on the expression of NKG2D ligands in myeloma cells. Valproic Acid killer cell lectin like receptor K1 Homo sapiens
3 In this study, we tested the effect of valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, on the expression of NKG2D ligands in myeloma cells. Valproic Acid killer cell lectin like receptor K1 Homo sapiens
4 These data indicate that increased sensitivity of VPA-treated myeloma cells to NK cell lysis is caused by higher NKG2D ligand expression, resulting from more active ERK signaling pathway. Valproic Acid killer cell lectin like receptor K1 Homo sapiens